Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma

Authors

Benjamin M. Ellingson, University of California - Los Angeles
Eunhee Kim, Brown University
Davis C. Woodworth, University of California - Los Angeles
Helga Marques, Brown University
Jerrold L. Boxerman, Brown University
Yair Safriel, University of South Florida
Robert C. McKinstry, Washington University School of Medicine in St. Louis
Felix Bokstein, Tel Aviv Sourasky Medical Center
Rajan Jain, Henry Ford Hospital
T. Linda Chi, University of Texas M.D. Anderson Cancer Center
A. Gregory Sorensen, Harvard University
Mark R. Gilbert, University of Texas M.D. Anderson Cancer Center
Daniel P. Barboriak, Duke University

Journal

International Journal of Oncology

Publication Date

2015

Volume

46

Inclusive Pages

1883-1892

Document Type

Open Access Publication

DOI

10.3892/ijo.2015.2891

Rights and Permissions

Ellingson, B.M., et al (2015). Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma. International Journal of Oncology, 46, 1883-1892. http://dx.doi.org/10.3892/ijo.2015.2891

Recommended Citation

Ellingson, Benjamin M.; Kim, Eunhee; Woodworth, Davis C.; Marques, Helga; Boxerman, Jerrold L.; Safriel, Yair; McKinstry, Robert C.; Bokstein, Felix; Jain, Rajan; Chi, T. Linda; Sorensen, A. Gregory; Gilbert, Mark R.; and Barboriak, Daniel P., "Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma." International Journal of Oncology. 46, 1883-1892. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/3806